Research Program | Ceribell (original) (raw)

Ceribell is used in 450+ hospitals nationwide and has helped them manage the care of more than 120,000 emergency and critical care patients.*

In the spirit of advancing patient care, we invite investigators to submit requests for study support using the form below.

Submissions will be evaluated by a cross-functional team of experts for scientific rigor, technical feasibility, investigator qualifications, support needs, and strategic fit.

Current areas of strategic interest include, but are not limited to:

• Adult seizure detection / nonconvulsive status epilepticus, particularly:
  • in areas with limited access to EEG, such as the emergency department
  • clinical and economic impact of seizure burden, as reported by our Clarity AI algorithm
• Future AI algorithm development and outcomes improvement beyond seizures

Recent peer-reviewed publications from investigator-initiated studies supported by our program include:

**Kalkach-Aparicio M., Fatima S., Selte A., et al. Seizure Assessment and Forecasting With Efficient Rapid-EEG: A Retrospective Multicenter Comparative Effectiveness Study. Neurology. 2024 Jul 23;103(2):e209621. doi: 10.1212/WNL.0000000000209621. Epub 2024 Jun 14. PMID: 38875512.

**Desai, M., Kalkach-Aparicio, M., Sheikh, I.S. et al. Evaluating the Impact of Point-of-Care Electroencephalography on Length of Stay in the Intensive Care Unit: Subanalysis of the SAFER-EEG Trial. Neurocrit Care (2024). https://doi.org/10.1007/s12028-024-02039-6

*Stats as of May 2024
** Support is not contingent upon the use, purchase, or recommendation of Ceribell’s products

We look forward to hearing from you.

By submitting I confirm that I have read and agree to the Privacy Statement.